JP2002121112A - Skin care preparation - Google Patents
Skin care preparationInfo
- Publication number
- JP2002121112A JP2002121112A JP2000313196A JP2000313196A JP2002121112A JP 2002121112 A JP2002121112 A JP 2002121112A JP 2000313196 A JP2000313196 A JP 2000313196A JP 2000313196 A JP2000313196 A JP 2000313196A JP 2002121112 A JP2002121112 A JP 2002121112A
- Authority
- JP
- Japan
- Prior art keywords
- extract
- skin
- andrographis
- production example
- skin care
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 238000002360 preparation method Methods 0.000 title claims abstract description 21
- 239000000284 extract Substances 0.000 claims abstract description 47
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 35
- 241000746375 Andrographis Species 0.000 claims description 16
- 150000001298 alcohols Chemical class 0.000 claims description 4
- 239000007788 liquid Substances 0.000 claims description 4
- 239000002904 solvent Substances 0.000 claims description 3
- 150000005846 sugar alcohols Polymers 0.000 claims description 3
- 230000003712 anti-aging effect Effects 0.000 claims 1
- 239000003795 chemical substances by application Substances 0.000 claims 1
- 230000037303 wrinkles Effects 0.000 abstract description 9
- 230000003078 antioxidant effect Effects 0.000 abstract description 7
- 244000118350 Andrographis paniculata Species 0.000 abstract description 3
- 244000131360 Morinda citrifolia Species 0.000 abstract description 3
- 235000008898 Morinda citrifolia Nutrition 0.000 abstract description 3
- 235000017524 noni Nutrition 0.000 abstract description 3
- 241001555141 Sauropus Species 0.000 abstract 2
- 238000004519 manufacturing process Methods 0.000 description 34
- PUPZLCDOIYMWBV-UHFFFAOYSA-N (+/-)-1,3-Butanediol Chemical compound CC(O)CCO PUPZLCDOIYMWBV-UHFFFAOYSA-N 0.000 description 32
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 30
- 229940058015 1,3-butylene glycol Drugs 0.000 description 16
- 235000019437 butane-1,3-diol Nutrition 0.000 description 16
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 15
- 239000000203 mixture Substances 0.000 description 15
- 239000012071 phase Substances 0.000 description 12
- 239000000047 product Substances 0.000 description 12
- 239000008213 purified water Substances 0.000 description 12
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 11
- -1 lipid peroxides Chemical class 0.000 description 11
- 239000001301 oxygen Substances 0.000 description 11
- 229910052760 oxygen Inorganic materials 0.000 description 11
- 239000000469 ethanolic extract Substances 0.000 description 10
- 238000009472 formulation Methods 0.000 description 10
- 241000196324 Embryophyta Species 0.000 description 9
- 239000006071 cream Substances 0.000 description 9
- 230000000694 effects Effects 0.000 description 9
- 239000003921 oil Substances 0.000 description 9
- 235000019198 oils Nutrition 0.000 description 9
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 8
- 238000010438 heat treatment Methods 0.000 description 8
- GVJHHUAWPYXKBD-UHFFFAOYSA-N d-alpha-tocopherol Natural products OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 7
- 230000002000 scavenging effect Effects 0.000 description 7
- 239000000243 solution Substances 0.000 description 7
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 6
- 102000019197 Superoxide Dismutase Human genes 0.000 description 6
- 108010012715 Superoxide dismutase Proteins 0.000 description 6
- 238000002835 absorbance Methods 0.000 description 6
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 6
- 238000000034 method Methods 0.000 description 6
- 239000000523 sample Substances 0.000 description 6
- 238000003756 stirring Methods 0.000 description 6
- 239000003205 fragrance Substances 0.000 description 5
- 230000003405 preventing effect Effects 0.000 description 5
- 235000021122 unsaturated fatty acids Nutrition 0.000 description 5
- 150000004670 unsaturated fatty acids Chemical class 0.000 description 5
- 239000008346 aqueous phase Substances 0.000 description 4
- 235000011187 glycerol Nutrition 0.000 description 4
- 239000004615 ingredient Substances 0.000 description 4
- 235000010270 methyl p-hydroxybenzoate Nutrition 0.000 description 4
- 239000004292 methyl p-hydroxybenzoate Substances 0.000 description 4
- LXCFILQKKLGQFO-UHFFFAOYSA-N methylparaben Chemical compound COC(=O)C1=CC=C(O)C=C1 LXCFILQKKLGQFO-UHFFFAOYSA-N 0.000 description 4
- 229960002216 methylparaben Drugs 0.000 description 4
- VBICKXHEKHSIBG-UHFFFAOYSA-N 1-monostearoylglycerol Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCC(O)CO VBICKXHEKHSIBG-UHFFFAOYSA-N 0.000 description 3
- ZWEHNKRNPOVVGH-UHFFFAOYSA-N 2-Butanone Chemical compound CCC(C)=O ZWEHNKRNPOVVGH-UHFFFAOYSA-N 0.000 description 3
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 3
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 description 3
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 3
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 3
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 3
- LRHPLDYGYMQRHN-UHFFFAOYSA-N N-Butanol Chemical compound CCCCO LRHPLDYGYMQRHN-UHFFFAOYSA-N 0.000 description 3
- 229920003171 Poly (ethylene oxide) Polymers 0.000 description 3
- KWYUFKZDYYNOTN-UHFFFAOYSA-M Potassium hydroxide Chemical compound [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 description 3
- 229930003427 Vitamin E Natural products 0.000 description 3
- 230000032683 aging Effects 0.000 description 3
- 239000003963 antioxidant agent Substances 0.000 description 3
- 235000006708 antioxidants Nutrition 0.000 description 3
- 239000007864 aqueous solution Substances 0.000 description 3
- 239000013040 bath agent Substances 0.000 description 3
- BTANRVKWQNVYAZ-UHFFFAOYSA-N butan-2-ol Chemical compound CCC(C)O BTANRVKWQNVYAZ-UHFFFAOYSA-N 0.000 description 3
- 239000004359 castor oil Substances 0.000 description 3
- 235000019438 castor oil Nutrition 0.000 description 3
- 229960000541 cetyl alcohol Drugs 0.000 description 3
- 238000006243 chemical reaction Methods 0.000 description 3
- 230000000052 comparative effect Effects 0.000 description 3
- 239000003814 drug Substances 0.000 description 3
- 239000000839 emulsion Substances 0.000 description 3
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 description 3
- 239000000499 gel Substances 0.000 description 3
- ZEMPKEQAKRGZGQ-XOQCFJPHSA-N glycerol triricinoleate Natural products CCCCCC[C@@H](O)CC=CCCCCCCCC(=O)OC[C@@H](COC(=O)CCCCCCCC=CC[C@@H](O)CCCCCC)OC(=O)CCCCCCCC=CC[C@H](O)CCCCCC ZEMPKEQAKRGZGQ-XOQCFJPHSA-N 0.000 description 3
- BXWNKGSJHAJOGX-UHFFFAOYSA-N hexadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCO BXWNKGSJHAJOGX-UHFFFAOYSA-N 0.000 description 3
- 229940057995 liquid paraffin Drugs 0.000 description 3
- 239000006210 lotion Substances 0.000 description 3
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 3
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 3
- 239000002674 ointment Substances 0.000 description 3
- 230000003647 oxidation Effects 0.000 description 3
- 238000007254 oxidation reaction Methods 0.000 description 3
- 239000002304 perfume Substances 0.000 description 3
- 239000008363 phosphate buffer Substances 0.000 description 3
- BDERNNFJNOPAEC-UHFFFAOYSA-N propan-1-ol Chemical compound CCCO BDERNNFJNOPAEC-UHFFFAOYSA-N 0.000 description 3
- 239000012085 test solution Substances 0.000 description 3
- 235000019165 vitamin E Nutrition 0.000 description 3
- 239000011709 vitamin E Substances 0.000 description 3
- 229940046009 vitamin E Drugs 0.000 description 3
- LRFVTYWOQMYALW-UHFFFAOYSA-N 9H-xanthine Chemical compound O=C1NC(=O)NC2=C1NC=N2 LRFVTYWOQMYALW-UHFFFAOYSA-N 0.000 description 2
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 2
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 2
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 2
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 2
- UQSXHKLRYXJYBZ-UHFFFAOYSA-N Iron oxide Chemical compound [Fe]=O UQSXHKLRYXJYBZ-UHFFFAOYSA-N 0.000 description 2
- IMNFDUFMRHMDMM-UHFFFAOYSA-N N-Heptane Chemical compound CCCCCCC IMNFDUFMRHMDMM-UHFFFAOYSA-N 0.000 description 2
- UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical compound [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 description 2
- 235000021355 Stearic acid Nutrition 0.000 description 2
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 description 2
- GWEVSGVZZGPLCZ-UHFFFAOYSA-N Titan oxide Chemical compound O=[Ti]=O GWEVSGVZZGPLCZ-UHFFFAOYSA-N 0.000 description 2
- 229930003268 Vitamin C Natural products 0.000 description 2
- 238000013329 compounding Methods 0.000 description 2
- NOPFSRXAKWQILS-UHFFFAOYSA-N docosan-1-ol Chemical compound CCCCCCCCCCCCCCCCCCCCCCO NOPFSRXAKWQILS-UHFFFAOYSA-N 0.000 description 2
- 229940079593 drug Drugs 0.000 description 2
- 150000002148 esters Chemical class 0.000 description 2
- NUVBSKCKDOMJSU-UHFFFAOYSA-N ethylparaben Chemical compound CCOC(=O)C1=CC=C(O)C=C1 NUVBSKCKDOMJSU-UHFFFAOYSA-N 0.000 description 2
- 238000000605 extraction Methods 0.000 description 2
- 239000000706 filtrate Substances 0.000 description 2
- 229930195733 hydrocarbon Natural products 0.000 description 2
- 150000002430 hydrocarbons Chemical class 0.000 description 2
- QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 description 2
- OQCDKBAXFALNLD-UHFFFAOYSA-N octadecanoic acid Natural products CCCCCCCC(C)CCCCCCCCC(O)=O OQCDKBAXFALNLD-UHFFFAOYSA-N 0.000 description 2
- 239000004006 olive oil Substances 0.000 description 2
- 235000008390 olive oil Nutrition 0.000 description 2
- 239000000843 powder Substances 0.000 description 2
- 102220240796 rs553605556 Human genes 0.000 description 2
- 239000001509 sodium citrate Substances 0.000 description 2
- NLJMYIDDQXHKNR-UHFFFAOYSA-K sodium citrate Chemical compound O.O.[Na+].[Na+].[Na+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O NLJMYIDDQXHKNR-UHFFFAOYSA-K 0.000 description 2
- 239000007787 solid Substances 0.000 description 2
- PRAKJMSDJKAYCZ-UHFFFAOYSA-N squalane Chemical compound CC(C)CCCC(C)CCCC(C)CCCCC(C)CCCC(C)CCCC(C)C PRAKJMSDJKAYCZ-UHFFFAOYSA-N 0.000 description 2
- 239000008117 stearic acid Substances 0.000 description 2
- 235000019154 vitamin C Nutrition 0.000 description 2
- 239000011718 vitamin C Substances 0.000 description 2
- 239000000230 xanthan gum Substances 0.000 description 2
- 229920001285 xanthan gum Polymers 0.000 description 2
- 229940082509 xanthan gum Drugs 0.000 description 2
- 235000010493 xanthan gum Nutrition 0.000 description 2
- BGRXBNZMPMGLQI-UHFFFAOYSA-N 2-octyldodecyl tetradecanoate Chemical compound CCCCCCCCCCCCCC(=O)OCC(CCCCCCCC)CCCCCCCCCC BGRXBNZMPMGLQI-UHFFFAOYSA-N 0.000 description 1
- HIQIXEFWDLTDED-UHFFFAOYSA-N 4-hydroxy-1-piperidin-4-ylpyrrolidin-2-one Chemical compound O=C1CC(O)CN1C1CCNCC1 HIQIXEFWDLTDED-UHFFFAOYSA-N 0.000 description 1
- DKPFZGUDAPQIHT-UHFFFAOYSA-N Butyl acetate Natural products CCCCOC(C)=O DKPFZGUDAPQIHT-UHFFFAOYSA-N 0.000 description 1
- 244000025254 Cannabis sativa Species 0.000 description 1
- 102000008186 Collagen Human genes 0.000 description 1
- 108010035532 Collagen Proteins 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 241000221017 Euphorbiaceae Species 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- 239000004166 Lanolin Substances 0.000 description 1
- OYHQOLUKZRVURQ-HZJYTTRNSA-N Linoleic acid Chemical compound CCCCC\C=C/C\C=C/CCCCCCCC(O)=O OYHQOLUKZRVURQ-HZJYTTRNSA-N 0.000 description 1
- 239000004372 Polyvinyl alcohol Substances 0.000 description 1
- 241000208422 Rhododendron Species 0.000 description 1
- 241001107098 Rubiaceae Species 0.000 description 1
- DBMJMQXJHONAFJ-UHFFFAOYSA-M Sodium laurylsulphate Chemical compound [Na+].CCCCCCCCCCCCOS([O-])(=O)=O DBMJMQXJHONAFJ-UHFFFAOYSA-M 0.000 description 1
- 229920002125 Sokalan® Polymers 0.000 description 1
- OUUQCZGPVNCOIJ-UHFFFAOYSA-M Superoxide Chemical compound [O-][O] OUUQCZGPVNCOIJ-UHFFFAOYSA-M 0.000 description 1
- GSEJCLTVZPLZKY-UHFFFAOYSA-N Triethanolamine Chemical compound OCCN(CCO)CCO GSEJCLTVZPLZKY-UHFFFAOYSA-N 0.000 description 1
- 108010093894 Xanthine oxidase Proteins 0.000 description 1
- 102100033220 Xanthine oxidase Human genes 0.000 description 1
- 239000006096 absorbing agent Substances 0.000 description 1
- DPXJVFZANSGRMM-UHFFFAOYSA-N acetic acid;2,3,4,5,6-pentahydroxyhexanal;sodium Chemical compound [Na].CC(O)=O.OCC(O)C(O)C(O)C(O)C=O DPXJVFZANSGRMM-UHFFFAOYSA-N 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 230000002411 adverse Effects 0.000 description 1
- 239000000443 aerosol Substances 0.000 description 1
- SOIFLUNRINLCBN-UHFFFAOYSA-N ammonium thiocyanate Chemical compound [NH4+].[S-]C#N SOIFLUNRINLCBN-UHFFFAOYSA-N 0.000 description 1
- 230000003064 anti-oxidating effect Effects 0.000 description 1
- 235000010323 ascorbic acid Nutrition 0.000 description 1
- 239000011668 ascorbic acid Substances 0.000 description 1
- 229960005070 ascorbic acid Drugs 0.000 description 1
- 235000013871 bee wax Nutrition 0.000 description 1
- 239000012166 beeswax Substances 0.000 description 1
- 239000000440 bentonite Substances 0.000 description 1
- 229910000278 bentonite Inorganic materials 0.000 description 1
- SVPXDRXYRYOSEX-UHFFFAOYSA-N bentoquatam Chemical compound O.O=[Si]=O.O=[Al]O[Al]=O SVPXDRXYRYOSEX-UHFFFAOYSA-N 0.000 description 1
- 239000012490 blank solution Substances 0.000 description 1
- 239000007844 bleaching agent Substances 0.000 description 1
- 125000000484 butyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 239000001768 carboxy methyl cellulose Substances 0.000 description 1
- 239000002738 chelating agent Substances 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 229920001436 collagen Polymers 0.000 description 1
- 238000004040 coloring Methods 0.000 description 1
- 239000000306 component Substances 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 239000002537 cosmetic Substances 0.000 description 1
- 239000003599 detergent Substances 0.000 description 1
- 230000006866 deterioration Effects 0.000 description 1
- 235000014113 dietary fatty acids Nutrition 0.000 description 1
- 238000010790 dilution Methods 0.000 description 1
- 239000012895 dilution Substances 0.000 description 1
- POLCUAVZOMRGSN-UHFFFAOYSA-N dipropyl ether Chemical compound CCCOCCC POLCUAVZOMRGSN-UHFFFAOYSA-N 0.000 description 1
- 229960000735 docosanol Drugs 0.000 description 1
- 239000002552 dosage form Substances 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 235000013399 edible fruits Nutrition 0.000 description 1
- 150000002170 ethers Chemical class 0.000 description 1
- 235000010228 ethyl p-hydroxybenzoate Nutrition 0.000 description 1
- 239000004403 ethyl p-hydroxybenzoate Substances 0.000 description 1
- 239000003925 fat Substances 0.000 description 1
- 235000019197 fats Nutrition 0.000 description 1
- 239000000194 fatty acid Substances 0.000 description 1
- 229930195729 fatty acid Natural products 0.000 description 1
- 150000004665 fatty acids Chemical class 0.000 description 1
- 229960002089 ferrous chloride Drugs 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 238000004108 freeze drying Methods 0.000 description 1
- FUZZWVXGSFPDMH-UHFFFAOYSA-N hexanoic acid Chemical compound CCCCCC(O)=O FUZZWVXGSFPDMH-UHFFFAOYSA-N 0.000 description 1
- 239000003906 humectant Substances 0.000 description 1
- 230000001771 impaired effect Effects 0.000 description 1
- 229910052742 iron Inorganic materials 0.000 description 1
- NMCUIPGRVMDVDB-UHFFFAOYSA-L iron dichloride Chemical compound Cl[Fe]Cl NMCUIPGRVMDVDB-UHFFFAOYSA-L 0.000 description 1
- 229940119170 jojoba wax Drugs 0.000 description 1
- 150000002576 ketones Chemical class 0.000 description 1
- 235000019388 lanolin Nutrition 0.000 description 1
- 229940039717 lanolin Drugs 0.000 description 1
- 235000020778 linoleic acid Nutrition 0.000 description 1
- OYHQOLUKZRVURQ-IXWMQOLASA-N linoleic acid Natural products CCCCC\C=C/C\C=C\CCCCCCCC(O)=O OYHQOLUKZRVURQ-IXWMQOLASA-N 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 229910052751 metal Inorganic materials 0.000 description 1
- 239000002184 metal Substances 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- JXTPJDDICSTXJX-UHFFFAOYSA-N n-Triacontane Natural products CCCCCCCCCCCCCCCCCCCCCCCCCCCCCC JXTPJDDICSTXJX-UHFFFAOYSA-N 0.000 description 1
- JPXMTWWFLBLUCD-UHFFFAOYSA-N nitro blue tetrazolium(2+) Chemical compound COC1=CC(C=2C=C(OC)C(=CC=2)[N+]=2N(N=C(N=2)C=2C=CC=CC=2)C=2C=CC(=CC=2)[N+]([O-])=O)=CC=C1[N+]1=NC(C=2C=CC=CC=2)=NN1C1=CC=C([N+]([O-])=O)C=C1 JPXMTWWFLBLUCD-UHFFFAOYSA-N 0.000 description 1
- 229940073665 octyldodecyl myristate Drugs 0.000 description 1
- 235000014593 oils and fats Nutrition 0.000 description 1
- 230000001590 oxidative effect Effects 0.000 description 1
- 239000000049 pigment Substances 0.000 description 1
- 239000002798 polar solvent Substances 0.000 description 1
- 239000000244 polyoxyethylene sorbitan monooleate Substances 0.000 description 1
- 235000010482 polyoxyethylene sorbitan monooleate Nutrition 0.000 description 1
- 239000001818 polyoxyethylene sorbitan monostearate Substances 0.000 description 1
- 235000010989 polyoxyethylene sorbitan monostearate Nutrition 0.000 description 1
- 229920000053 polysorbate 80 Polymers 0.000 description 1
- 229920002451 polyvinyl alcohol Polymers 0.000 description 1
- 239000013641 positive control Substances 0.000 description 1
- 239000003755 preservative agent Substances 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 239000012488 sample solution Substances 0.000 description 1
- 230000009759 skin aging Effects 0.000 description 1
- 230000037393 skin firmness Effects 0.000 description 1
- 239000000344 soap Substances 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 229910000030 sodium bicarbonate Inorganic materials 0.000 description 1
- 235000017557 sodium bicarbonate Nutrition 0.000 description 1
- 235000019812 sodium carboxymethyl cellulose Nutrition 0.000 description 1
- 229920001027 sodium carboxymethylcellulose Polymers 0.000 description 1
- 238000001694 spray drying Methods 0.000 description 1
- 229940032094 squalane Drugs 0.000 description 1
- 239000012089 stop solution Substances 0.000 description 1
- AKEJUJNQAAGONA-UHFFFAOYSA-N sulfur trioxide Inorganic materials O=S(=O)=O AKEJUJNQAAGONA-UHFFFAOYSA-N 0.000 description 1
- 239000004094 surface-active agent Substances 0.000 description 1
- 239000000454 talc Substances 0.000 description 1
- 229910052623 talc Inorganic materials 0.000 description 1
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 description 1
- 239000002562 thickening agent Substances 0.000 description 1
- 239000004408 titanium dioxide Substances 0.000 description 1
- 229930003799 tocopherol Natural products 0.000 description 1
- 235000010384 tocopherol Nutrition 0.000 description 1
- 229960001295 tocopherol Drugs 0.000 description 1
- 239000011732 tocopherol Substances 0.000 description 1
- 239000001993 wax Substances 0.000 description 1
- 229940075420 xanthine Drugs 0.000 description 1
- GVJHHUAWPYXKBD-IEOSBIPESA-N α-tocopherol Chemical compound OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-IEOSBIPESA-N 0.000 description 1
Landscapes
- Cosmetics (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
Description
【0001】[0001]
【発明の属する技術分野】本発明は、特定の植物の抽出
物を配合することにより、肌のうるおい、ハリ、しわ及
びくすみ改善作用に優れた皮膚外用剤に関する。The present invention relates to an external preparation for skin which is excellent in improving skin moisture, firmness, wrinkles and dullness by incorporating an extract of a specific plant.
【0002】[0002]
【従来の技術】近年、生体成分を酸化させる要因とし
て、フリーラジカルや活性酸素がとりあげられ、その悪
影響が問題となっている。フリーラジカルや活性酸素は
生体内で生じ、コラーゲン等の生体組織を分解あるいは
架橋し、また、油脂類を酸化して、細胞に障害を与える
過酸化脂質をつくると言われている。この様な障害は、
肌のハリの低下、しわ等の老化の原因になると考えられ
ており、老化を防ぐ方法の一つにフリーラジカルや活性
酸素を除去する抗酸化剤を配合する方法が知られてい
る。従来、老化防止を目的として用いられる抗酸化剤に
はアスコルビン酸(ビタミンC)、トコフェロール(ビ
タミンE)、3,5-tert-ブチル-4-ヒドロキシトルエン
(BHT)、スーパーオキシドジスムターゼ(SOD)
等が用いられてきた。2. Description of the Related Art In recent years, free radicals and active oxygen have been taken up as factors for oxidizing biological components, and their adverse effects have become a problem. It is said that free radicals and active oxygen are generated in the living body, decompose or crosslink biological tissues such as collagen, and oxidize fats and oils to produce lipid peroxides that damage cells. Such obstacles,
It is thought to cause aging such as reduction of skin firmness and wrinkles, and a method of adding an antioxidant for removing free radicals and active oxygen is known as one of the methods for preventing aging. Conventionally, antioxidants used for the purpose of preventing aging include ascorbic acid (vitamin C), tocopherol (vitamin E), 3,5-tert-butyl-4-hydroxytoluene (BHT), superoxide dismutase (SOD)
Etc. have been used.
【0003】[0003]
【発明が解決しようとする課題】皮膚の老化防止又は抗
酸化を目的として用いられるビタミンCやスーパーオキ
シドジスムターゼは不安定であり、製剤化が難しく、ビ
タミンEも効果が充分であるとは言えない。また、合成
化合物であるBHT等は安全性に問題があり、配合量に
制限があることから、化学合成品ではなく、安定でかつ
副作用の少ない天然原料が望まれている。Vitamin C and superoxide dismutase used for the purpose of preventing skin aging or antioxidation are unstable, difficult to formulate, and vitamin E cannot be said to be sufficiently effective. . Also, BHT and the like, which are synthetic compounds, have a problem in safety and are limited in the blending amount. Therefore, natural materials that are stable and have few side effects are desired instead of chemically synthesized products.
【0004】以上のことから、安全であり、しわ及びハ
リ改善作用に優れるばかりでなく、肌のうるおい、及び
くすみ改善作用に効果的な皮膚外用剤が望まれている。[0004] In view of the above, there is a demand for an external preparation for skin that is not only safe and has excellent wrinkle and firmness-improving effects, but is also effective in improving skin moisture and dullness.
【0005】この様な事情により、本発明者らは鋭意研
究を重ねた結果、アマメシバ、アンドログラフィス又は
ヤエヤマアオキの抽出物が、不飽和脂肪酸酸化防止作用
及び活性酸素消去作用に優れ、安定性においても優れて
いることを見出した。さらに、アマメシバ、アンドログ
ラフィス、ヤエヤマアオキから一種又は二種以上選ばれ
る抽出物を含有する皮膚外用剤が、安全であり、肌のう
るおい、ハリ、しわ及びくすみ改善作用に優れているこ
とを見出し、本発明を完成するに至った。[0005] Under such circumstances, the present inventors have conducted intensive studies, and as a result, it was found that the extract of Amamushiba, Andrographis or Yaeyamaaki was excellent in the action of preventing the oxidation of unsaturated fatty acids and the action of eliminating active oxygen, and also in terms of stability. I found it to be excellent. Furthermore, it has been found that an external preparation for skin containing an extract selected from one or more of Amamushiba, Andrographis, and Yaeyamaaki is safe and excellent in improving the moisture, firmness, wrinkles and dullness of the skin. The invention has been completed.
【0006】すなわち、本発明は、アマメシバ、アンド
ログラフィス、ヤエヤマアオキから一種又は二種以上選
ばれる抽出物を含有することを特徴とする皮膚外用剤で
ある。[0006] That is, the present invention is an external preparation for skin, characterized by containing one or more extracts selected from Amamigrass, Andrographis and Yaeyamaaki.
【0007】本発明で用いるアマメシバ(学名:Saurop
us androgynous)は、トウダイグサ科の植物である。ア
ンドログラフィス(学名:Andrographis paniculata、
別名: Sambiloto)は、キツネノマゴ科の植物である。
ヤエヤマアオキ(学名:Morinda citrifolia、別名: M
engkudu)は、アカネ科の植物である。これらは主に東
南アジアに分布し、生薬として広く使用されている。[0007] Amamigrass (scientific name: Saurop) used in the present invention
us androgynous) is a plant of the family Euphorbiaceae. Andrographies (scientific name: Andrographis paniculata,
Alias: Sambiloto) is a plant of the family Rhododendron.
Yaeyama Aoki (scientific name: Morinda citrifolia, aka: M
engkudu) is a plant of the family Rubiaceae. These are mainly distributed in Southeast Asia and are widely used as crude drugs.
【0008】本発明で用いる抽出物は、上記の葉、茎、
樹皮、花、実、根等の植物体の一部又は全草から抽出し
たものであるが、特に限定されるものではなく、目的に
応じて適宜選択すれば良い。抽出方法は特に限定され
ず、例えば、加熱抽出したものであっても良いし、常温
抽出したものであっても良い。[0008] The extract used in the present invention comprises the leaves, stems,
It is extracted from a part of a plant such as bark, flower, fruit, root or whole plant, but is not particularly limited and may be appropriately selected according to the purpose. The extraction method is not particularly limited, and may be, for example, the one extracted by heating or the one extracted at room temperature.
【0009】抽出する溶媒としては、例えば、水、低級
アルコール類(メタノール、エタノール、1-プロパノー
ル、2-プロパノール、1-ブタノール、2-ブタノール
等)、液状多価アルコール(1,3-ブチレングリコール、
プロピレングリコール、グリセリン等)、ケトン類(ア
セトン、メチルエチルケトン等)、アセトニトリル、エ
ステル類(酢酸エチル、酢酸ブチル等)、炭化水素類
(ヘキサン、ヘプタン、流動パラフィン等)、エーテル
類(エチルエーテル、テトラヒドロフラン、プロピルエ
ーテル等)が挙げられる。好ましくは、水、低級アルコ
ール及び液状多価アルコール等の極性溶媒が良く、特に
好ましくは、水、エタノール、1,3-ブチレングリコール
及びプロピレングリコールが良い。これらの溶媒は一種
でも二種以上を混合して用いても良い。Examples of the solvent to be extracted include water, lower alcohols (methanol, ethanol, 1-propanol, 2-propanol, 1-butanol, 2-butanol, etc.) and liquid polyhydric alcohol (1,3-butylene glycol). ,
Propylene glycol, glycerin, etc.), ketones (acetone, methyl ethyl ketone, etc.), acetonitrile, esters (ethyl acetate, butyl acetate, etc.), hydrocarbons (hexane, heptane, liquid paraffin, etc.), ethers (ethyl ether, tetrahydrofuran, Propyl ether). Preferred are polar solvents such as water, lower alcohols and liquid polyhydric alcohols, and particularly preferred are water, ethanol, 1,3-butylene glycol and propylene glycol. These solvents may be used alone or in combination of two or more.
【0010】上記抽出物は、抽出した溶液のまま用いて
も良く、必要に応じて、濃縮、希釈、濾過等の処理をし
て用いても良い。更には、抽出した溶液を濃縮乾固、噴
霧乾燥、凍結乾燥等の処理を行い、乾燥物として用いて
も良い。The above-mentioned extract may be used as it is as an extracted solution, or may be used after being subjected to a treatment such as concentration, dilution, or filtration, if necessary. Further, the extracted solution may be subjected to a treatment such as concentration and drying, spray drying, and freeze drying to be used as a dried product.
【0011】本発明の皮膚外用剤には、上記抽出物をそ
のまま使用しても良く、抽出物の効果を損なわない範囲
内で、通常の外用剤に用いられる成分である油脂類、ロ
ウ類、炭化水素類、脂肪酸類、アルコール類、エステル
類、界面活性剤、金属石鹸、pH調整剤、防腐剤、香料、
保湿剤、粉体、紫外線吸収剤、増粘剤、色素、酸化防止
剤、美白剤、キレート剤等の成分を配合することもでき
る。The above-mentioned extract may be used as it is in the external preparation for skin of the present invention, and oils and fats, waxes, and the like, which are components used in general external preparations, as long as the effect of the extract is not impaired. Hydrocarbons, fatty acids, alcohols, esters, surfactants, metal soaps, pH adjusters, preservatives, fragrances,
Components such as humectants, powders, ultraviolet absorbers, thickeners, pigments, antioxidants, whitening agents, chelating agents and the like can also be blended.
【0012】本発明の皮膚外用剤は、化粧品、医薬部外
品及び医薬品のいずれにも用いることができ、その剤型
としては、例えば、化粧水、クリーム、乳液、ゲル剤、
エアゾール剤、軟膏、パップ剤、エッセンス、パック、
洗浄剤、浴用剤、ファンデーション、打粉、口紅等の皮
膚に適用されるものが挙げられる。The external preparation for skin of the present invention can be used in any of cosmetics, quasi-drugs and pharmaceuticals. Examples of the dosage form include lotions, creams, emulsions, gels,
Aerosol, ointment, poultice, essence, pack,
Those applied to the skin, such as detergents, bath agents, foundations, powders, lipsticks, etc.
【0013】本発明に用いる上記抽出物の配合量は、本
発明の皮膚外用剤全量に対し、固形物に換算して0.0001
重量%以上、好ましくは 0.001〜10重量%が良い。0.00
01重量%未満では十分な効果は望みにくい。10重量%を
越えて配合した場合、効果の増強はみられにくく不経済
である。また、添加の方法については、予め加えておい
ても、製造途中で添加しても良く、作業性を考えて適宜
選択すれば良い。The amount of the above-mentioned extract used in the present invention is 0.0001 in terms of solid based on the total amount of the external preparation for skin of the present invention.
% Or more, preferably 0.001 to 10% by weight. 0.00
If it is less than 01% by weight, a sufficient effect is hardly expected. When the content is more than 10% by weight, the effect is hardly enhanced and it is uneconomical. The method of addition may be added in advance or may be added during the production, and may be appropriately selected in consideration of workability.
【0014】[0014]
【実施例】次に本発明を詳細に説明するため、実施例と
して本発明に用いる抽出物の製造例、本発明の処方例及
び実験例を挙げるが、本発明はこれに限定されるもので
はない。実施例に示す配合量の部とは重量部を示し、%
は重量%を示す。EXAMPLES In order to explain the present invention in detail, examples of the production of the extract used in the present invention, prescription examples of the present invention and experimental examples will be given below, but the present invention is not limited to these examples. Absent. Parts in the amounts shown in Examples are parts by weight, and%
Indicates% by weight.
【0015】製造例1 アマメシバの熱水抽出物 アマメシバの葉の乾燥物20gに精製水400mLを加え、95〜
100℃で2時間抽出した後、濾過し、その濾液を濃縮
し、凍結乾燥してアマメシバの熱水抽出物を5.0g得た。Production Example 1 Hot water extract of Amamigrass Purified water (400 mL) was added to 20 g of dried matter of Amamigrass leaves.
After extraction at 100 ° C. for 2 hours, the mixture was filtered, and the filtrate was concentrated and freeze-dried to obtain 5.0 g of a hot water extract of Amabashiba.
【0016】製造例2 アマメシバの50%エタノール抽
出物 アマメシバの全草の乾燥物100gに精製水1L及びエタノー
ル1Lを加え、常温で7日間抽出した後、濾過し、その濾
液を濃縮乾固して、アマメシバの50%エタノール抽出物
を18g得た。Preparation Example 2 50% Ethanol Extract of Amamigrass 1 L of purified water and 1 L of ethanol were added to 100 g of dried whole grass of Amamigrass, extracted at room temperature for 7 days, filtered, and the filtrate was concentrated to dryness. As a result, 18 g of a 50% ethanol extract of Amamigrass was obtained.
【0017】製造例3 アマメシバの1,3-ブチレングリ
コール抽出物 アマメシバの根の乾燥物100gに1,3-ブチレングリコール
1.0kgを加え、常温で7日間抽出した後、濾過し、アマ
メシバの1,3-ブチレングリコール抽出物を0.91kg得た。Production Example 3 1,3-butylene glycol extract of Amamigrass 1,3-butyleneglycol was added to 100 g of dried amamigrass root.
After adding 1.0 kg and extracting at normal temperature for 7 days, the mixture was filtered to obtain 0.91 kg of 1,3-butylene glycol extract of Amamushiba.
【0018】製造例4 アンドログラフィスの熱水抽出
物 アンドログラフィスの葉の乾燥物20gを製造例1と同様
に抽出してアンドログラフィスの熱水抽出物を3.0g得
た。Production Example 4 Hot Water Extract of Andrographis 20 g of a dried Andrographis leaf was extracted in the same manner as in Production Example 1 to obtain 3.0 g of a hot water extract of Andrography.
【0019】製造例5 アンドログラフィスの50%エタ
ノール抽出物 アンドログラフィスの全草の乾燥物100gを製造例2と同
様に抽出してアンドログラフィスの50%エタノール抽出
物を12g得た。Preparation Example 5 A 50% ethanol extract of Andrography was extracted in the same manner as in Preparation Example 2 by extracting 100 g of a dried plant of Andrography's whole plant to obtain 12 g of a 50% ethanol extract of Andrography.
【0020】製造例6 アンドログラフィスの1,3-ブチ
レングリコール抽出物 アマメシバの根の乾燥物100gを製造例3と同様に抽出し
てアンドログラフィスの1,3-ブチレングリコール抽出物
を0.93kg得た。Production Example 6 1,3-butylene glycol extract of Andrographis 100 g of dried dried Amamigrass root was extracted in the same manner as in Production Example 3 to obtain 0.93 kg of a 1,3-butylene glycol extract of Andrographis. .
【0021】製造例7 ヤエヤマアオキの熱水抽出物 ヤエヤマアオキの葉の乾燥物20gを製造例1と同様に抽
出してヤエヤマアオキの熱水抽出物を3.2g得た。Production Example 7 Hot Water Extract of Yaeyama Aoki The dried product of leaves of Yaeyama Aoki was extracted in the same manner as in Production Example 1 to obtain 3.2 g of a hot water extract of Yaeyama Aoki.
【0022】製造例8 ヤエヤマアオキの50%エタノー
ル抽出物 ヤエヤマアオキの全草の乾燥物100gを製造例2と同様に
抽出してヤエヤマアオキの50%エタノール抽出物を23g
得た。Preparation Example 8 50% Ethanol Extract of Yaeyama Aoki 100 g of dried whole plant of Yaeyama Aoki was extracted in the same manner as in Production Example 2 to obtain 23 g of a 50% ethanol extract of Yaeyama Aoki.
Obtained.
【0023】製造例9 ヤエヤマアオキの1,3-ブチレン
グリコール抽出物 ヤエヤマアオキの根の乾燥物100gを製造例3と同様に抽
出してヤエヤマアオキの1,3-ブチレングリコール抽出物
を0.93kg得た。Production Example 9 1,3-butylene glycol extract of Ayamayama oki 100 g of dried yaeyamaaki root was extracted in the same manner as in Production Example 3 to obtain 0.93 kg of a 1,3-butyleneglycol extract of Ayamayamaoki.
【0024】 実施例1 クリーム1 処方 配合量 1. アマメシバの熱水抽出物(製造例1) 1.0部 2. スクワラン 5.5 3. オリーブ油 3.0 4. ステアリン酸 2.0 5. ミツロウ 2.0 6. ミリスチン酸オクチルドデシル 3.5 7. ポリオキシエチレンセチルエーテル(20E.O.) 3.0 8. ベヘニルアルコール 1.5 9. モノステアリン酸グリセリン 2.5 10. 香料 0.1 11. 1,3-ブチレングリコール 8.5 12. パラオキシ安息香酸エチル 0.05 13. パラオキシ安息香酸メチル 0.2 14. 精製水にて全量を100とする [製造方法]成分2〜9を加熱溶解して混合し、70℃に保
ち油相とする。成分 1及び11〜14を加熱溶解して混合
し、75℃に保ち水相とする。油相に水相を加えて乳化し
て、かき混ぜながら冷却し、45℃で成分10を加え、更に
30℃まで冷却して製品とする。Example 1 Cream 1 Prescription Formulation Amount 1. Hot water extract of Amamushiba (Preparation Example 1) 1.0 part 2. Squalane 5.5 3. Olive oil 3.0 4. Stearic acid 2.0 5. Beeswax 2.0 6. Octyldodecyl myristate 3.5 7. Polyoxyethylene cetyl ether (20E.O.) 3.0 8. Behenyl alcohol 1.5 9. Glycerin monostearate 2.5 10. Fragrance 0.1 11. 1,3-butylene glycol 8.5 12. Ethyl parahydroxybenzoate 0.05 13. Paraoxybenzoic acid Methyl 0.2 14. Make the total amount 100 with purified water. [Production method] Heat and dissolve components 2 to 9 and mix. Maintain at 70 ° C to obtain an oil phase. Components 1 and 11 to 14 are dissolved by heating and mixed, and kept at 75 ° C. to obtain an aqueous phase. Add the water phase to the oil phase, emulsify, cool with stirring, add component 10 at 45 ° C,
Cool to 30 ° C to obtain a product.
【0025】実施例2 クリーム2 実施例1において、アマメシバの熱水抽出物をアンドロ
グラフィスの熱水抽出物(製造例4)に置き換えたもの
をクリーム2とした。Example 2 Cream 2 Cream 2 was prepared in the same manner as in Example 1 except that the hot water extract of Amamigrass was replaced by a hot water extract of Andrographis (Production Example 4).
【0026】実施例3 クリーム3 実施例1において、アマメシバの熱水抽出物をヤエヤマ
アオキの熱水抽出物(製造例7)に置き換えたものをク
リーム3とした。Example 3 Cream 3 Cream 3 was prepared in the same manner as in Example 1 except that the hot water extract of Amamushiba was replaced with the hot water extract of Yaeyama Aoki (Production Example 7).
【0027】比較例1 従来のクリーム 実施例1において、アマメシバの熱水抽出物を精製水に
置き換えたものを従来のクリームとした。COMPARATIVE EXAMPLE 1 Conventional Cream A conventional cream was prepared by replacing the hot water extract of Amamushiba with purified water in Example 1.
【0028】 実施例4 化粧水 処方 配合量 1. アマメシバの50%エタノール抽出物(製造例2) 0.1部 2. アンドログラフィスの50%エタノール抽出物(製造例5) 0.1 3. ヤエヤマアオキの50%エタノール抽出物(製造例8) 0.1 4. 1,3-ブチレングリコール 8.0 5. グリセリン 2.0 6. キサンタンガム 0.02 7. クエン酸 0.01 8. クエン酸ナトリウム 0.1 9. エタノール 5.0 10. パラオキシ安息香酸メチル 0.1 11. ポリオキシエチレン硬化ヒマシ油(40E.O.) 0.1 12. 香料 適量 13. 精製水にて全量を100とする [製造方法]成分1〜8及び13と、成分9〜12をそれぞれ
均一に溶解し、両者を混合し濾過して製品とする。Example 4 Lotion Formulation Formulation amount 1. 0.1% of 50% ethanol extract of Amamushiba (Production Example 2) 2. 50% ethanol extract of Andrographis (Production Example 5) 0.1 3. 50% ethanol of Yaeyama Aoki Extract (Production Example 8) 0.1 4. 1,3-butylene glycol 8.0 5. Glycerin 2.0 6. Xanthan gum 0.02 7. Citric acid 0.01 8. Sodium citrate 0.1 9. Ethanol 5.0 10. Methyl parahydroxybenzoate 0.1 11. Poly Oxyethylene hydrogenated castor oil (40E.O.) 0.1 12. Appropriate amount of fragrance 13. Make the total amount 100 with purified water [Production method] Components 1 to 8 and 13 and components 9 to 12 are each dissolved uniformly. Both are mixed and filtered to obtain a product.
【0029】 実施例5 乳液 処方 配合量 1. アマメシバの1,3-ブチレングリコール抽出物(製造例3) 0.5部 2. オリーブ油 5.0 3. ホホバ油 5.0 4. セタノール 1.5 5. モノステアリン酸グリセリン 2.0 6. ポリオキシエチレンセチルエーテル(20E.O.) 3.0 7. ポリオキシエチレンソルビタンモノオレエート(20E.O.) 2.0 8. 香料 0.1 9. プロピレングリコール 1.0 10. グリセリン 2.0 11. パラオキシ安息香酸メチル 0.2 12. 精製水にて全量を100とする [製造方法]成分2〜7を加熱溶解して混合し、70℃に保
ち油相とする。成分 1及び9〜12を加熱溶解して混合
し、75℃に保ち水相とする。油相に水相を加えて乳化し
て、かき混ぜながら冷却し、45℃で成分8を加え、更に3
0℃まで冷却して製品とする。Example 5 Emulsion Prescription Formulation Amount 1. 0.5 part of 1,3-butylene glycol extract of Amamushiba (Production Example 3) 2. Olive oil 5.0 3. Jojoba oil 5.0 4. Cetanol 1.5 5. Glycerin monostearate 2.0 6 Polyoxyethylene cetyl ether (20E.O.) 3.0 7. Polyoxyethylene sorbitan monooleate (20E.O.) 2.0 8. Fragrance 0.1 9. Propylene glycol 1.0 10. Glycerin 2.0 11. Methyl paraoxybenzoate 0.2 12 Adjust the total amount to 100 with purified water. [Production method] Components 2 to 7 are dissolved by heating and mixed, and kept at 70 ° C to obtain an oil phase. Components 1 and 9 to 12 are dissolved by heating and mixed, and kept at 75 ° C. to obtain an aqueous phase. Add the water phase to the oil phase, emulsify, cool with stirring, add component 8 at 45 ° C, and add
Cool to 0 ° C to obtain a product.
【0030】 実施例6 ゲル剤 処方 配合量 1. アンドログラフィスの1,3-ブチレングリコール(製造例6) 0.01部 2. エタノール 5.0 3. パラオキシ安息香酸メチル 0.1 4. ポリオキシエチレン硬化ヒマシ油(60E.O.) 0.1 5. 香料 適量 6. 1,3-ブチレングリコール 5.0 7. グリセリン 5.0 8. キサンタンガム 0.1 9. カルボキシビニルポリマー 0.2 10. 水酸化カリウム 0.2 11. 精製水にて全量を100とする [製造方法]成分2〜5と、成分1及び6〜11をそれぞれ均
一に溶解し、両者を混合して製品とする。Example 6 Gel Formulation Formulation Amount 1. Andrographics 1,3-butylene glycol (Production Example 6) 0.01 part 2. Ethanol 5.0 3. Methyl parahydroxybenzoate 0.1 4. Polyoxyethylene hydrogenated castor oil (60E) .O.) 0.1 5. Appropriate amount of perfume 6. 1,3-butylene glycol 5.0 7. Glycerin 5.0 8. Xanthan gum 0.1 9. Carboxyvinyl polymer 0.2 10. Potassium hydroxide 0.2 11. Make the total amount 100 with purified water [ Production method] Components 2 to 5, and components 1 and 6 to 11 are each dissolved uniformly, and both are mixed to form a product.
【0031】 実施例7 軟膏 処方 配合量 1. アマメシバの熱水抽出物(製造例1) 1.0部 2. アンドログラフィスの熱水抽出物(製造例4) 1.0 3. ポリオキシエチレンセチルエーテル(30E.O.) 2.0 4. モノステアリン酸グリセリン 10.0 5. 流動パラフィン 5.0 6. セタノール 6.0 7. パラオキシ安息香酸メチル 0.1 8. プロピレングリコール 10.0 9. 精製水にて全量を100とする [製造方法]成分3〜6を加熱溶解して混合し、70℃に保
ち油相とする。成分1、2及び7〜9を加熱溶解して混合
し、75℃に保ち水相とする。油相に水相を加えて乳化し
て、かき混ぜながら30℃まで冷却して製品とする。Example 7 Ointment Prescription Formulation amount 1. Hot water extract of Amamushiba (Production Example 1) 1.0 part 2. Hot water extract of Andrographis (Production Example 4) 1.0 3. Polyoxyethylene cetyl ether (30E. O.) 2.0 4. Glycerin monostearate 10.0 5. Liquid paraffin 5.0 6. Cetanol 6.0 7. Methyl parahydroxybenzoate 0.1 8. Propylene glycol 10.0 9. Make the total amount to 100 with purified water. 6 is dissolved by heating and mixed, and kept at 70 ° C. to obtain an oil phase. Components 1, 2 and 7 to 9 are dissolved by heating and mixed, and the mixture is kept at 75 ° C. to form an aqueous phase. Add the water phase to the oil phase, emulsify and cool to 30 ° C with stirring to obtain the product.
【0032】 実施例8 パック 処方 配合量 1. アンドログラフィスの50%エタノール抽出物(製造例5) 0.1部 2. ヤエヤマアオキの熱水抽出物(製造例7) 0.1 3. ポリビニルアルコール 12.0 4. エタノール 5.0 5. 1,3-ブチレングリコール 8.0 6. パラオキシ安息香酸メチル 0.2 7. ポリオキシエチレン硬化ヒマシ油(20E.O.) 0.5 8. クエン酸 0.1 9. クエン酸ナトリウム 0.3 10. 香料 適量 11. 精製水にて全量を100とする [製造方法]成分1〜11を均一に溶解し製品とする。Example 8 Pack Formulation Compounding amount 1. 0.1 part of 50% ethanol extract of Andrographis (Production Example 5) 2. Hot water extract of Yaeyama Aoki (Production Example 7) 0.1 3. Polyvinyl alcohol 12.0 4. Ethanol 5.0 5. 1,3-butylene glycol 8.0 6. Methyl paraoxybenzoate 0.2 7. Polyoxyethylene hydrogenated castor oil (20E.O.) 0.5 8. Citric acid 0.1 9. Sodium citrate 0.3 10. Perfume qs 11. Purified water [Production method] Components 1 to 11 are uniformly dissolved to give a product.
【0033】 実施例9 ファンデーション 処方 配合量 1. ヤエヤマアオキの1,3-ブチレングリコール抽出物(製造例9) 1.0部 2. ステアリン酸 2.4 3. ポリオキシエチレンソルビタンモノステアレート(20E.O.) 1.0 4. ポリオキシエチレンセチルエーテル(20E.O.) 2.0 5. セタノール 1.0 6. 液状ラノリン 2.0 7. 流動パラフィン 3.0 8. ミリスチン酸イソプロピル 6.5 9. パラオキシ安息香酸ブチル 0.1 10. カルボキシメチルセルロースナトリウム 0.1 11. ベントナイト 0.5 12. プロピレングリコール 4.0 13. トリエタノールアミン 1.1 14. パラオキシ安息香酸メチル 0.2 15. 二酸化チタン 8.0 16. タルク 4.0 17. ベンガラ 1.0 18. 黄酸化鉄 2.0 19. 香料 適量 20. 精製水にて全量を100とする [製造方法]成分2〜9を加熱溶解し、80℃に保ち油相と
する。成分20に成分10をよく膨潤させ、続いて、成分1
及び11〜14を加えて均一に混合する。これに粉砕機で粉
砕混合した成分15〜18を加え、ホモミキサーで撹拌し75
℃に保ち水相とする。この水相に油相をかき混ぜながら
加え、冷却し、45℃で成分19を加え、かき混ぜながら30
℃まで冷却して製品とする。Example 9 Foundation Formulation Compounding amount 1. 1.0 part of 1,3-butylene glycol extract of Aeyama aki (Production Example 9) 2. Stearic acid 2.4 3. Polyoxyethylene sorbitan monostearate (20E.O.) 1.0 4. Polyoxyethylene cetyl ether (20E.O.) 2.0 5. Cetanol 1.0 6. Liquid lanolin 2.0 7. Liquid paraffin 3.0 8. Isopropyl myristate 6.5 9. Butyl paraoxybenzoate 0.1 10. Sodium carboxymethyl cellulose 0.1 11. Bentonite 0.5 12. Propylene glycol 4.0 13. Triethanolamine 1.1 14. Methyl parahydroxybenzoate 0.2 15. Titanium dioxide 8.0 16. Talc 4.0 17. Bengala 1.0 18. Yellow iron oxide 2.0 19. Fragrance qs. 20. Purified water [Production method] Components 2 to 9 are heated and dissolved, and kept at 80 ° C to obtain an oil phase. Swell the ingredient 10 well to the ingredient 20, then add the ingredient 1
And 11 to 14 are added and mixed uniformly. Add the ingredients 15 to 18 crushed and mixed with a crusher to this, and stir with a homomixer for 75
Keep at ℃ and make water phase. Add the oil phase to this aqueous phase with stirring, cool, add component 19 at 45 ° C, and stir with 30
Cool to ℃ to make the product.
【0034】 実施例10 浴用剤 処方 配合量 1. アマメシバの50%エタノール抽出物(製造例2) 5.0部 2. 炭酸水素ナトリウム 50.0 3. 黄色202号(1) 適量 4. 香料 適量 5. 無水硫酸ナトリウムにて全量を100とする [製造方法]成分1〜5を均一に混合し製品とする。Example 10 Bath agent Prescription Formulation amount 1. 50% ethanol extract of Amamushiba (Production Example 2) 5.0 parts 2. Sodium bicarbonate 50.0 3. Yellow 202 (1) qs 4. Perfume qs 5. Sulfuric anhydride The total amount is adjusted to 100 with sodium. [Production method] Components 1 to 5 are uniformly mixed to obtain a product.
【0035】次に、本発明の効果を詳細に説明するた
め、実験例を挙げる。Next, experimental examples will be described in order to explain the effects of the present invention in detail.
【0036】実験例1 不飽和脂肪酸酸化防止作用の測
定方法(抗酸化作用) 試料0.5mg(固形分当たり)、0.02mg/mLリノール酸・エ
タノール溶液2mL、エタノール1mL及び0.2Mリン酸緩衝液
(pH 7.0)1mLを精製水で全量5mLとする。50℃で8日間
反応させ、試験液とし、ロダン鉄法によって吸光度を測
定した。すなわち、各試験液0.1mLに75%(v/v)エタノ
ール4.7mL、30%チオシアン酸アンモニウム水溶液0.1mL
及び0.02M塩化第一鉄塩酸溶液0.1mLを加え、3分間放置
後、波長500nmにおける吸光度(A)を測定した。一
方、ブランクとして試料を添加しない試験液を用いて同
様に操作し、吸光度(B)を測定した。また、ビタミン
Eを比較品とした。各試料の不飽和脂肪酸酸化防止作用
は以下に示す式より算出した。 不飽和脂肪酸酸化防止率(%)=(1−A÷B)×10
0EXPERIMENTAL EXAMPLE 1 Method for Measuring Unsaturated Fatty Acid Antioxidant Activity (Antioxidant Activity) A sample 0.5 mg (per solid), 0.02 mg / mL linoleic acid / ethanol solution 2 mL, ethanol 1 mL and 0.2 M phosphate buffer ( Adjust the volume to 1 mL with purified water (pH 7.0). The reaction was carried out at 50 ° C. for 8 days to prepare a test solution, and the absorbance was measured by the rodin iron method. That is, 0.1mL of each test solution is 4.7mL of 75% (v / v) ethanol, 0.1mL of 30% ammonium thiocyanate aqueous solution
And 0.1 mL of 0.02 M ferrous chloride / hydrochloric acid solution was added, and the mixture was allowed to stand for 3 minutes, and then the absorbance (A) at a wavelength of 500 nm was measured. On the other hand, the same operation was performed using a test solution to which no sample was added as a blank, and the absorbance (B) was measured. In addition, vitamin E was used as a comparative product. The unsaturated fatty acid oxidation preventing action of each sample was calculated by the following equation. Unsaturated fatty acid oxidation prevention rate (%) = (1-A ÷ B) × 10
0
【0037】これらの試験結果を表1に示した。その結
果、アマメシバ、アンドログラフィス及びヤエヤマアオ
キの抽出物は、優れた不飽和脂肪酸酸化防止作用を示し
た。Table 1 shows the results of these tests. As a result, the extracts of Amamushiba, Andrographis and Yaeyamaaki showed excellent antioxidant action of unsaturated fatty acids.
【0038】[0038]
【表1】 [Table 1]
【0039】実験例2 活性酸素消去作用(抗酸化作
用) 製造例1〜9を試料として用い、活性酸素の一種である
スーパーオキシドの消去作用を測定した。陽性対照とし
て、スーパーオキシドジスムターゼ(SOD)を用い
た。また、試料の安定性を確認するために、試料の水溶
液を95℃で1時間加熱した液を使用して同様に測定を行
った。Experimental Example 2 Active oxygen scavenging action (antioxidant action) Using Production Examples 1 to 9 as samples, the scavenging action of superoxide, a kind of active oxygen, was measured. Superoxide dismutase (SOD) was used as a positive control. In addition, in order to confirm the stability of the sample, the same measurement was performed using a solution obtained by heating an aqueous solution of the sample at 95 ° C. for 1 hour.
【0040】活性酸素消去作用の測定方法 各濃度の試料水溶液0.1mLに0.45mLの発色試薬(0.24mM
ニトロブルーテトラゾリウム、0.4mMキサンチンを含む
0.1Mリン酸緩衝液;pH8.0)と0.45mLの酵素液(0.1U/mL
キサンチンオキシダーゼ)を加え、37℃で20分間反応さ
せジホルマザンを生じさせた。この溶液に反応停止液
(69mMドデシル硫酸ナトリウム水溶液)1.0mLを加えた
後、波長560nmにおける吸光度(At)を測定した。同様
に酵素液の代わりにブランク液(0.1Mリン酸緩衝液;pH
8.0)を加えて反応させ、吸光度(As)を測定した。一
方、コントロールとして試料溶液の代わりに精製水を用
いて同様に操作し、吸光度(Bt)及び(Bs)を測定
した。各試料の活性酸素消去率は次式より算出した。 活性酸素消去率(%)={1−(As−At)÷(Bs
−Bt)}×100Method of measuring active oxygen scavenging action 0.45 mL of a coloring reagent (0.24 mM
Nitro blue tetrazolium, containing 0.4 mM xanthine
0.1 M phosphate buffer; pH 8.0 and 0.45 mL enzyme solution (0.1 U / mL)
Xanthine oxidase) was added and reacted at 37 ° C. for 20 minutes to produce diformazan. After adding 1.0 mL of a reaction stop solution (69 mM sodium dodecyl sulfate aqueous solution) to this solution, the absorbance (At) at a wavelength of 560 nm was measured. Similarly, a blank solution (0.1 M phosphate buffer; pH
8.0) was added thereto for reaction, and the absorbance (As) was measured. On the other hand, the same operation was performed using purified water instead of the sample solution as a control, and the absorbances (Bt) and (Bs) were measured. The active oxygen scavenging rate of each sample was calculated by the following equation. Active oxygen scavenging rate (%) = {1- (As-At)} (Bs
−Bt)} × 100
【0041】これらの試験結果を表2に示した。また、
SODは95℃で1時間の加熱により、活性酸素消去作用
が大きく減少したが、アマメシバ、アンドログラフィス
及びヤエヤマアオキの抽出物は消去作用に変化はなかっ
た。以上のことから、アマメシバ、アンドログラフィス
及びヤエヤマアオキの抽出物は、95℃の加熱にも安定で
優れた活性酸素消去作用を示した。Table 2 shows the results of these tests. Also,
For SOD, the active oxygen scavenging effect was greatly reduced by heating at 95 ° C. for 1 hour, whereas the extract of Amamushiba, Andrographis and Yaeyamaaki was not changed. From the above, the extracts of Amamushiba, Andrographis and Yaeyamaaki showed stable and excellent active oxygen scavenging action even when heated at 95 ° C.
【0042】[0042]
【表2】 [Table 2]
【0043】実験例3 使用試験 実施例1〜3のクリーム及び比較例1の従来のクリーム
を用いて、各々女性30人(30〜45才)を対象に1
ヶ月間の使用試験を行った。使用後、肌のうるおい、ハ
リ、しわ及びくすみの改善を総合的に判断するアンケー
ト調査を行った。EXPERIMENTAL EXAMPLE 3 Use Test Using the creams of Examples 1 to 3 and the conventional cream of Comparative Example 1, 30 women (30 to 45 years old) were used as subjects.
A month-long use test was performed. After use, a questionnaire survey was conducted to comprehensively judge the improvement of skin moisture, firmness, wrinkles and dullness.
【0044】その結果、当該皮膚外用剤は、肌のうるお
い、ハリ、しわ及びくすみの改善に関して優れた作用を
示した(表3)。なお、試験期間中、皮膚トラブルは一
人もなく、安全性においても問題なかった。また、処方
成分の劣化についても問題なかった。As a result, the external preparation for skin showed an excellent effect on improvement of skin moisture, firmness, wrinkles and dullness (Table 3). During the test period, there was no skin trouble and there was no problem in safety. Also, there was no problem with the deterioration of the prescription components.
【0045】[0045]
【表3】 [Table 3]
【0046】実施例4の化粧水、実施例5の乳液、実施
例6のゲル剤、実施例7の軟膏、実施例8のパック、実
施例9のファンデーション及び実施例10の浴用剤につ
いても使用試験を行ったところ、安全であり、肌のうる
おい、ハリ、しわ及びくすみの改善作用に優れていた。Also used for the lotion of Example 4, the emulsion of Example 5, the gel of Example 6, the ointment of Example 7, the pack of Example 8, the foundation of Example 9, and the bath agent of Example 10. The test showed that it was safe and had an excellent effect of improving skin moisture, firmness, wrinkles and dullness.
【0047】[0047]
【発明の効果】以上のことから、本発明のアマメシバ、
アンドログラフィス、ヤエヤマアオキから一種又は二種
以上選ばれる抽出物は、抗酸化作用、安定性に優れてい
た。さらに、これらの抽出物を含有する皮膚外用剤は、
安全であり、肌のうるおい、ハリ、しわ及びくすみの改
善作用に優れていた。From the above, it can be seen from the above that the amamigrass of the present invention,
One or more extracts selected from Andrographis and Yaeyamaaki were excellent in antioxidant action and stability. In addition, skin external preparations containing these extracts,
It was safe and excellent in improving skin moisture, firmness, wrinkles and dullness.
───────────────────────────────────────────────────── フロントページの続き (51)Int.Cl.7 識別記号 FI テーマコート゛(参考) A61P 43/00 107 A61P 43/00 107 Fターム(参考) 4C083 AA082 AA111 AA112 AA122 AB232 AB242 AB312 AB352 AB432 AB442 AC022 AC072 AC102 AC122 AC182 AC242 AC302 AC342 AC422 AC432 AC442 AC482 AC542 AC842 AD112 AD272 AD352 CC04 CC05 CC07 CC12 CC25 DD21 DD32 DD41 EE12 FF01 4C088 AB14 AB46 AC01 AC03 AC04 AC05 AC11 CA05 CA06 CA09 MA63 ZA89 ZB22 ──────────────────────────────────────────────────続 き Continued on the front page (51) Int.Cl. 7 Identification code FI theme coat ゛ (reference) A61P 43/00 107 A61P 43/00 107 F term (reference) 4C083 AA082 AA111 AA112 AA122 AB232 AB242 AB312 AB352 AB432 AB442 AC022 AC072 AC102 AC122 AC182 AC242 AC302 AC342 AC422 AC432 AC442 AC482 AC542 AC842 AD112 AD272 AD352 CC04 CC05 CC07 CC12 CC25 DD21 DD32 DD41 EE12 FF01 4C088 AB14 AB46 AC01 AC03 AC04 AC05 AC11 CA05 CA06 CA09 MA63 ZA89 ZB22
Claims (3)
エヤマアオキから一種又は二種以上選ばれる抽出物を含
有することを特徴とする皮膚外用剤。1. An external preparation for skin, characterized by containing an extract selected from one or more of amamishiba, andrography, and yaeyamaaki.
価アルコールから一種又は二種以上選ばれる溶媒による
抽出物であることを特徴とする請求項1記載の皮膚外用
剤。2. The external preparation for skin according to claim 1, wherein the extract is an extract using one or more solvents selected from water, lower alcohols and liquid polyhydric alcohols.
エヤマアオキから一種又は二種以上選ばれる抽出物を含
有することを特徴とする老化防止剤。3. An anti-aging agent comprising an extract selected from one or more selected from the group consisting of Amamushiba, Andrographis, and Yaeyamaaki.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2000313196A JP4489923B2 (en) | 2000-10-13 | 2000-10-13 | Topical skin preparation |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2000313196A JP4489923B2 (en) | 2000-10-13 | 2000-10-13 | Topical skin preparation |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2002121112A true JP2002121112A (en) | 2002-04-23 |
| JP4489923B2 JP4489923B2 (en) | 2010-06-23 |
Family
ID=18792651
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2000313196A Expired - Lifetime JP4489923B2 (en) | 2000-10-13 | 2000-10-13 | Topical skin preparation |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JP4489923B2 (en) |
Cited By (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2003128569A (en) * | 2001-10-18 | 2003-05-08 | Maruzen Pharmaceut Co Ltd | Skin care preparation, drink and food |
| JP2007176934A (en) * | 2005-11-30 | 2007-07-12 | Kose Corp | Platelet-activating factor acetylhydrolase function regulator |
| JP2009149562A (en) * | 2007-12-20 | 2009-07-09 | Oppen Keshohin Kk | External preparation for skin |
| JP2009280549A (en) * | 2008-05-26 | 2009-12-03 | Tahitian Noni Internatl Inc | Elastase inhibitor |
| JP2010013400A (en) * | 2008-07-04 | 2010-01-21 | Ichimaru Pharcos Co Ltd | Melanin formation inhibitor |
| JP2010090093A (en) * | 2008-10-10 | 2010-04-22 | Maruzen Pharmaceut Co Ltd | Type i collagen production promotor, filaggrin production promoter, involucrin production promoter, and transglutaminase 1 production promoter |
| KR100955572B1 (en) * | 2004-06-21 | 2010-04-30 | 주식회사 코리아나화장품 | Cosmetic composition containing noni supercritical extract |
| JP2012067061A (en) * | 2010-09-27 | 2012-04-05 | Maruzen Pharmaceut Co Ltd | Maillard reaction inhibitor and aging improving agent |
| JP2013503866A (en) * | 2009-09-02 | 2013-02-04 | アクセス ビジネス グループ インターナショナル エルエルシー | Compositions and methods for skin repair |
| JP2013209299A (en) * | 2012-03-30 | 2013-10-10 | Kose Corp | Dna damage suppressant, and skin care preparation, cosmetic material and food and drink containing the same |
| US9149665B2 (en) | 2004-12-22 | 2015-10-06 | Avon Products, Inc. | Method and composition for reducing appearance of wrinkles |
| JP2015218157A (en) * | 2014-05-21 | 2015-12-07 | 花王株式会社 | Involucrin expression inhibitor |
| JP2016027023A (en) * | 2014-06-27 | 2016-02-18 | 株式会社コーセー | Skin external preparations or cosmetics |
| JP2019038754A (en) * | 2017-08-23 | 2019-03-14 | 一丸ファルコス株式会社 | Skin external preparation |
Citations (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH0930946A (en) * | 1995-07-21 | 1997-02-04 | Shiseido Co Ltd | Beautifying and whitening dermal preparation for external use |
| JPH0959167A (en) * | 1995-08-17 | 1997-03-04 | Fukunan O | Health food drug and method for producing the same |
| JPH1029927A (en) * | 1996-07-12 | 1998-02-03 | Shiseido Co Ltd | Antiaging agent |
| JP2000095663A (en) * | 1998-09-24 | 2000-04-04 | Kose Corp | Agent for external use containing plant extract |
| JP2000143437A (en) * | 1998-11-09 | 2000-05-23 | Ichimaru Pharcos Co Ltd | Cosmetic composition containing huhectant vegetable extract |
| JP2001199871A (en) * | 2000-01-24 | 2001-07-24 | Kanebo Ltd | Cosmetic |
| JP2001213752A (en) * | 2000-01-28 | 2001-08-07 | Kanebo Ltd | Cosmetic |
| JP2001213755A (en) * | 2000-01-31 | 2001-08-07 | Kanebo Ltd | Low irritation skin cosmetic |
-
2000
- 2000-10-13 JP JP2000313196A patent/JP4489923B2/en not_active Expired - Lifetime
Patent Citations (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH0930946A (en) * | 1995-07-21 | 1997-02-04 | Shiseido Co Ltd | Beautifying and whitening dermal preparation for external use |
| JPH0959167A (en) * | 1995-08-17 | 1997-03-04 | Fukunan O | Health food drug and method for producing the same |
| JPH1029927A (en) * | 1996-07-12 | 1998-02-03 | Shiseido Co Ltd | Antiaging agent |
| JP2000095663A (en) * | 1998-09-24 | 2000-04-04 | Kose Corp | Agent for external use containing plant extract |
| JP2000143437A (en) * | 1998-11-09 | 2000-05-23 | Ichimaru Pharcos Co Ltd | Cosmetic composition containing huhectant vegetable extract |
| JP2001199871A (en) * | 2000-01-24 | 2001-07-24 | Kanebo Ltd | Cosmetic |
| JP2001213752A (en) * | 2000-01-28 | 2001-08-07 | Kanebo Ltd | Cosmetic |
| JP2001213755A (en) * | 2000-01-31 | 2001-08-07 | Kanebo Ltd | Low irritation skin cosmetic |
Cited By (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2003128569A (en) * | 2001-10-18 | 2003-05-08 | Maruzen Pharmaceut Co Ltd | Skin care preparation, drink and food |
| KR100955572B1 (en) * | 2004-06-21 | 2010-04-30 | 주식회사 코리아나화장품 | Cosmetic composition containing noni supercritical extract |
| US9149665B2 (en) | 2004-12-22 | 2015-10-06 | Avon Products, Inc. | Method and composition for reducing appearance of wrinkles |
| JP2007176934A (en) * | 2005-11-30 | 2007-07-12 | Kose Corp | Platelet-activating factor acetylhydrolase function regulator |
| JP2009149562A (en) * | 2007-12-20 | 2009-07-09 | Oppen Keshohin Kk | External preparation for skin |
| JP2009280549A (en) * | 2008-05-26 | 2009-12-03 | Tahitian Noni Internatl Inc | Elastase inhibitor |
| JP2010013400A (en) * | 2008-07-04 | 2010-01-21 | Ichimaru Pharcos Co Ltd | Melanin formation inhibitor |
| JP2010090093A (en) * | 2008-10-10 | 2010-04-22 | Maruzen Pharmaceut Co Ltd | Type i collagen production promotor, filaggrin production promoter, involucrin production promoter, and transglutaminase 1 production promoter |
| JP2013503866A (en) * | 2009-09-02 | 2013-02-04 | アクセス ビジネス グループ インターナショナル エルエルシー | Compositions and methods for skin repair |
| JP2012067061A (en) * | 2010-09-27 | 2012-04-05 | Maruzen Pharmaceut Co Ltd | Maillard reaction inhibitor and aging improving agent |
| JP2013209299A (en) * | 2012-03-30 | 2013-10-10 | Kose Corp | Dna damage suppressant, and skin care preparation, cosmetic material and food and drink containing the same |
| JP2015218157A (en) * | 2014-05-21 | 2015-12-07 | 花王株式会社 | Involucrin expression inhibitor |
| JP2016027023A (en) * | 2014-06-27 | 2016-02-18 | 株式会社コーセー | Skin external preparations or cosmetics |
| JP2019038754A (en) * | 2017-08-23 | 2019-03-14 | 一丸ファルコス株式会社 | Skin external preparation |
Also Published As
| Publication number | Publication date |
|---|---|
| JP4489923B2 (en) | 2010-06-23 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JPH04342519A (en) | Skin cosmetic | |
| JP2002121112A (en) | Skin care preparation | |
| JP2003081749A (en) | Skin care preparation | |
| JP2009029734A (en) | External preparation for skin | |
| JP2003192566A (en) | Cosmetic | |
| JP5184840B2 (en) | Topical skin preparation | |
| JP2002121144A (en) | Skin care preparation | |
| JP5138262B2 (en) | Topical skin preparation | |
| JP4824181B2 (en) | Topical skin preparation | |
| JPH07258063A (en) | External preparation for skin | |
| JP3452671B2 (en) | External preparation for skin | |
| JP2000159653A (en) | Preparation for external use for skin | |
| JP3930165B2 (en) | Topical skin preparation | |
| JP2000319159A (en) | Skin preparation for external use | |
| JP3224962B2 (en) | External preparation for skin | |
| JP2003095857A (en) | Skin care preparation | |
| JP4402274B2 (en) | Topical skin preparation | |
| JPH04356416A (en) | Skin cosmetic | |
| JPH10203922A (en) | Cosmetic | |
| JP3499387B2 (en) | External preparation for skin | |
| JP2002241295A (en) | Skin care preparation | |
| JP5468866B2 (en) | Topical skin preparation | |
| JP2002121124A (en) | Skin care preparation | |
| JP3930179B2 (en) | Topical skin preparation | |
| JP4698810B2 (en) | Topical skin preparation |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| A711 | Notification of change in applicant |
Free format text: JAPANESE INTERMEDIATE CODE: A712 Effective date: 20041117 |
|
| A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20070820 |
|
| A977 | Report on retrieval |
Free format text: JAPANESE INTERMEDIATE CODE: A971007 Effective date: 20090127 |
|
| A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20091013 |
|
| A521 | Written amendment |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20091209 |
|
| A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20100112 |
|
| A521 | Written amendment |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20100224 |
|
| TRDD | Decision of grant or rejection written | ||
| A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 Effective date: 20100330 |
|
| A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 |
|
| A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20100401 |
|
| FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20130409 Year of fee payment: 3 |
|
| R150 | Certificate of patent or registration of utility model |
Ref document number: 4489923 Country of ref document: JP Free format text: JAPANESE INTERMEDIATE CODE: R150 Free format text: JAPANESE INTERMEDIATE CODE: R150 |
|
| FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20140409 Year of fee payment: 4 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |